Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand 
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics 
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Google Halts UK YouTube TV Measurement Service After Legal Action 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations 
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results 
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth 
ALLEN, Texas, May 23, 2017 -- Atrion Corporation (Nasdaq:ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.05 per share on the Company’s outstanding Common Stock. This dividend will be payable on June 30, 2017 to stockholders of record at the close of business on June 15, 2017.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800
